Does LERCANIDIPINE Cause Intentional product use issue? 21 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Intentional product use issue have been filed in association with LERCANIDIPINE. This represents 0.6% of all adverse event reports for LERCANIDIPINE.
21
Reports of Intentional product use issue with LERCANIDIPINE
0.6%
of all LERCANIDIPINE reports
0
Deaths
11
Hospitalizations
How Dangerous Is Intentional product use issue From LERCANIDIPINE?
Of the 21 reports, 11 (52.4%) required hospitalization.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LERCANIDIPINE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does LERCANIDIPINE Cause?
Acute kidney injury (424)
Hypotension (401)
Fall (323)
Hypertension (197)
Hyperkalaemia (176)
Drug ineffective (149)
Diarrhoea (122)
Hyponatraemia (122)
Renal impairment (120)
Oedema peripheral (114)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which LERCANIDIPINE Alternatives Have Lower Intentional product use issue Risk?
LERCANIDIPINE vs LETAIRIS
LERCANIDIPINE vs LETERMOVIR
LERCANIDIPINE vs LETROZOLE
LERCANIDIPINE vs LETROZOLE\RIBOCICLIB
LERCANIDIPINE vs LEUCOVORIN